
InfuSystem Holdings INFU
$ 9.44
2.88%
Quarterly report 2025-Q3
added 11-04-2025
Country |
|
IPO year |
- |
Industry |
Medical instruments |
Stock Exchange |
NYSE AMERICAN |
Shares |
20.6 M |
Market Cap[1] |
$ 195 M |
EBITDA (LTM) |
$ 24.6 M |
P/E (LTM) |
30.7 |
P/S (LTM) |
1.33 |
EPS (LTM) |
0.3 |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Ekso Bionics Holdings
EKSO
|
$ 10.38 | 3.78 % | $ 25.2 M | Nasdaq Capital Market | ||
|
AtriCure
ATRC
|
$ 31.1 | -1.16 % | $ 1.49 B | Nasdaq Global Market,SPB | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
The Cooper Companies
COO
|
$ 81.55 | -2.18 % | $ 16.2 B | NYSE,SPB | ||
|
Alcon
ALC
|
$ 83.49 | 0.49 % | $ 40.4 B | NYSE | ||
|
iRhythm Technologies
IRTC
|
$ 128.87 | 2.4 % | $ 4.12 B | Nasdaq Global Select Market,SPB | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Repro Med Systems
KRMD
|
$ 4.83 | 1.26 % | $ 220 M | Nasdaq Capital Market | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
LeMaitre Vascular
LMAT
|
$ 107.04 | -0.75 % | $ 2.42 B | Nasdaq Global Market,SPB | ||
|
Masimo Corporation
MASI
|
$ 175.45 | 0.05 % | $ 9.35 B | Nasdaq Global Select Market,SPB | ||
|
Baxter International
BAX
|
$ 18.79 | -1.18 % | $ 9.64 B | NYSE,SPB | ||
|
Microbot Medical
MBOT
|
$ 2.47 | 3.41 % | $ 25.2 M | Nasdaq Global Select Market | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Glaukos Corporation
GKOS
|
$ 116.45 | -1.1 % | $ 5.64 B | NYSE,SPB | ||
|
Haemonetics Corporation
HAE
|
$ 65.12 | -0.78 % | $ 3.28 B | NYSE,SPB | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
Harvard Bioscience
HBIO
|
$ 0.58 | 3.36 % | $ 24.6 M | Nasdaq Global Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 171.07 | -1.8 % | $ 49.2 B | NYSE,SPB | ||
|
ResMed
RMD
|
$ 257.17 | -0.43 % | $ 37.6 B | NYSE,SPB | ||
|
AngioDynamics
ANGO
|
$ 11.01 | -0.27 % | $ 450 M | Nasdaq Global Select Market | ||
|
Retractable Technologies
RVP
|
$ 0.69 | 3.38 % | $ 20.7 M | NYSE American | ||
|
BioLife Solutions
BLFS
|
$ 20.79 | 3.07 % | $ 958 M | Nasdaq Global Select Market | ||
|
Nephros
NEPH
|
$ 4.01 | 3.75 % | $ 41.6 M | Nasdaq Global Select Market | ||
|
electroCore
ECOR
|
$ 7.8 | 2.5 % | $ 43 K | Nasdaq Global Select Market | ||
|
Envista Holdings Corporation
NVST
|
$ 28.37 | -1.01 % | $ 4.77 B | NYSE | ||
|
Pulse Biosciences
PLSE
|
$ 18.31 | 2.01 % | $ 1.23 B | Nasdaq Global Select Market | ||
|
STERIS plc
STE
|
$ 244.79 | 0.59 % | $ 24.1 B | NYSE,SPB | ||
|
ICU Medical
ICUI
|
$ 141.43 | -0.86 % | $ 3.48 B | Nasdaq Global Select Market,SPB | ||
|
Intuitive Surgical
ISRG
|
$ 502.93 | 1.11 % | $ 179 B | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 125.51 | 1.99 % | $ 6.99 M | Nasdaq Global Select Market,SPB | ||
|
Teleflex Incorporated
TFX
|
$ 120.97 | -1.0 % | $ 5.4 B | NYSE,SPB | ||
|
Merit Medical Systems
MMSI
|
$ 74.9 | 0.07 % | $ 4.43 B | Nasdaq Global Select Market,SPB | ||
|
STAAR Surgical Company
STAA
|
$ 19.18 | 1.35 % | $ 951 M | Nasdaq Global Market,SPB | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
OraSure Technologies
OSUR
|
$ 3.01 | 1.01 % | $ 224 M | Nasdaq Global Select Market,SPB | ||
|
Pro-Dex
PDEX
|
$ 48.78 | 2.66 % | $ 160 M | Nasdaq Global Select Market | ||
|
Utah Medical Products
UTMD
|
$ 67.09 | 0.87 % | $ 243 M | Nasdaq Global Select Market | ||
|
West Pharmaceutical Services
WST
|
$ 249.41 | -0.72 % | $ 18 B | NYSE,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 13.46 | 1.17 % | $ 2.68 B | Nasdaq Global Select Market,SPB | ||
|
Stereotaxis
STXS
|
$ 2.19 | 2.57 % | $ 177 M | NYSE American | ||
|
Milestone Scientific
MLSS
|
$ 0.29 | 1.77 % | $ 23.1 M | NYSE American |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.